Physician profile
Joe S Johnson
NPI 1801893474
$1,528.83
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $380 · 2021: $424 · 2024: $52.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $267.61 | 2019-2021 | |
| Abbvie INC. | $176.81 | 2020-2021 | |
| Pfizer INC. | $175.29 | 2019-2020 | |
| Astellas Pharma US INC | $158.90 | 2019-2021 | |
| Amarin Pharma, INC. | $136.43 | 2019-2021 | |
| Glaxosmithkline, LLC. | $98.65 | 2019-2020 | |
| Novo Nordisk INC | $66.61 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $53.17 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.84 | 2019-2020 | |
| Duchesnay USA Incorporated | $37.65 | 2019 | |
| Ironshore Pharmaceuticals INC. | $36.02 | 2024 | |
| Allergan, INC. | $27.14 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $25.59 | 2021 | |
| Horizon Therapeutics Plc | $24.85 | 2019 | |
| Genentech USA, INC. | $23.67 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $23.58 | 2019 | |
| Lilly USA, LLC | $22.53 | 2019 | |
| Dexcom, INC. | $16.20 | 2024 | Dexcom G6 Transmitter |
| Medtronic USA, INC. | $16.17 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.14 | 2020 | |
| Nestle Healthcare Nutrition INC. | $15.26 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.81 | 2019 | |
| Radius Health, INC. | $12.76 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.89 | 2020 | |
| Merck Sharp & Dohme LLC | $11.24 | 2021 | |
| Eisai INC. | $11.09 | 2020 | |
| Sanofi Pasteur INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.